Floatz logo

Arestin

First Episode Psychosis

Stanley Medical Research InstitutePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the First Episode Psychosis cohort.

Asset / SponsorPhaseRating
Olanzapine
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 4BB
Risperdal
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 4BB
Seroquel®
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 4BB
Cipralex
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 4BB
Sertraline
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 4BB
CITALOPRAM
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 4BB
ZIPRASIDONE
Phase 4BB
TRIGLYCERIDES,MEDIUM CHAIN
Université de Sherbrooke
N/AD

Same molecule, other indications

Arestin is also rated in:

mood disorderDormant
BBB
Indicative ·
73 / 100
View asset →
bipolar depressionDormant
BB
Indicative ·
70 / 100
View asset →
ischemic strokeDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →